KB Financial Partners’s Quest Diagnostics DGX Stock Holding History

KB Financial Partners’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$2K	Hold	14	–	–	﹤0.01%	497
2023 Q2	$2K	Hold	14	–	–	﹤0.01%	518
2023 Q1	$2K	Hold	14	–	–	﹤0.01%	503
2022 Q4	$2K	Hold	14	–	–	﹤0.01%	503
2022 Q3	$2K	Hold	14	–	–	﹤0.01%	495
2022 Q2	$2K	Hold	14	–	–	﹤0.01%	497
2022 Q1	$2K	Hold	14	–	–	﹤0.01%	545
2021 Q4	$2K	Buy	+14	New	+$2.13K	﹤0.01%	582
2021 Q3	–	Sell	-14	Closed	-$2K	–	264
2021 Q2	$2K	Sell	14 -762	-98%	-$99.8K	﹤0.01%	554
2021 Q1	$100K	Buy	+776	New	+$95.6K	0.04%	205

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

KB Financial Partners's DGX Position: Q3 2023 in Review

KB Financial Partners held its Quest Diagnostics (DGX) position steady in Q3 2023 at 14 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #497.

KB Financial Partners first reported a position in DGX in Q1 2021 and has held it in 10 quarters since. The position peaked at $100K in Q1 2021. 794 funds tracked by Wall St. Rank hold DGX as of Q3 2023.

KB Financial Partners held 14 shares of Quest Diagnostics worth $2K as of Q3 2023.
KB Financial Partners left its Quest Diagnostics share count unchanged in Q3 2023.
Quest Diagnostics made up ﹤0.01% of KB Financial Partners's portfolio in Q3 2023, its #497 holding.
KB Financial Partners first reported a position in Quest Diagnostics in Q1 2021 and has held it in 10 quarters since.
KB Financial Partners's Quest Diagnostics position peaked at $100K in Q1 2021.
794 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2023.

Based on KB Financial Partners's 13F filing for Q3 2023, filed 15 Nov 2023.